Impax Laboratories [IPXL] is no longer included in the analysis because it is merging with Amneal Pharmaceuticals. Apergy Corp. [APY] has been added to the service.
Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. completed their business combination to form Amneal Pharmaceuticals, Inc. (“Amneal”). Shares of Impax (“IPXL”) ceased trading on the NASDAQ stock exchange on May 4, 2018. On May 7, 2018, shares of the new combined company, Amneal, began to trade on the New York Stock Exchange under the ticker “AMRX.
Dover (NYSE: DOV) announced today that its board of directors formally approved the separation of Apergy Corporation (“Apergy”) from Dover through a distribution of all of the common stock of Apergy held by Dover to Dover shareholders.